Sinopharm
1099.HK
$2.75
Share price
-1.15%
Change (1 day)
-19.59%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
EPS for Sinopharm (1099.HK)
EPS in 2022: $0.40
According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.40. In 2022 the company made an earnings per share (EPS) of $0.40 an increase over its 2021 EPS that were of $0.39.
EPS history for Sinopharm from 2006 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | $0.40 | 1.3% |
| 2021 | $0.39 | 10.33% |
| 2020 | $0.35 | 17.26% |
| 2019 | $0.30 | 5.44% |
| 2018 | $0.29 | -0.87% |
| 2017 | $0.29 | 19.44% |
| 2016 | $0.24 | 15.3% |
| 2015 | $0.21 | 17.06% |
| 2014 | $0.18 | 21.9% |
| 2013 | $0.15 | 11.82% |
| 2012 | $0.13 | 25.24% |
| 2011 | $0.11 | 31.02% |
| 2010 | $0.08015 | 3.3% |
| 2009 | $0.07759 | 46.85% |
| 2008 | $0.05284 | 67.57% |
| 2007 | $0.03153 | 310.24% |
| 2006 | $0.007686 |